[{"Assets_0_FY_USD":1900567000.0,"CommonStockSharesConverted_0_FY_shares":49406011.0,"CommonStockSharesOutstanding_0_FY_shares":49406011.0,"EarningsPerShareBasic_1_FY_USD":-2.52,"EarningsPerShareBasic_4_FY_USD":-7.71,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":-280553000.0,"NetIncomeLossConverted_1_FY_USD":-117228000.0,"NetIncomeLossConverted_4_FY_USD":-335643000.0,"RevenuesConverted_4_FY_USD":35427000.0,"RevenuesConverted_1_FY_USD":4168000.0,"StockholdersEquity_0_FY_USD":1623432000.0,"Ticker":"BLUE","CIK":"1293971","name":"BLUEBIRD BIO, INC.","OfficialName":"bluebird bio Inc. Common Stock","form":"10-K","period":"20171231","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"301448421.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20180221"}]